Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

Europe & US – 41 EVAR Physicians: Message Testing at Congress

Testing Aortic Messaging at Congress: 41 Interviews in Germany and Miami

Recruiting and researching at congresses provides the best chance to quickly and efficiently capture a true cross-section of physicians: ideal for Europe.

A manufacturer needed to finalize launch messaging for a new abdominal aortic stent-graft, as well as campaign messaging for its established device and broader aortic portfolio. The same interviews also explored…

 

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

Europe & US – 35 Physicians: In-Person Aortic Stent-Graft Interviews

Testing demand for a next-generation aortic stent-graft alongside its predecessor in London, Chicago, and New York

Some questions can't be answered from a screen. Physicians need to see and handle the device.

A manufacturer planned to launch a next-generation aortic stent-graft while keeping its established version on the market. It needed to know whether physicians saw value in having both.

Each one-hour structured interview…

 

Read More
Cardiology & Heart Failure Sharon Greyling Cardiology & Heart Failure Sharon Greyling

US – 20 CARDIOLOGISTS

Mapping the Heart Failure Referral Pathway, from Transplant Center to Private Practice

A cardiologist's practice setting shapes how they view advanced heart failure therapy and whether they refer for it.

A company developing a partial-support mechanical circulatory support device wanted to understand how US cardiologists would view it and where it might fit in the referral pathway.

The recruit was designed to cover the…

 

Read More
Vascular & Aortic Sharon Greyling Vascular & Aortic Sharon Greyling

US & Europe – 24 Vascular Specialists: Stent Graft Interviews at VEITH

Will a Next-Generation Stent Graft Change Practice? Asking High and Low Users at VEITH

By interviewing both heavy and light users of the current device, we estimated how far a next-generation version could shift treatment choices.

A manufacturer wanted to validate the scope of a next-generation balloon-expandable covered stent graft and judge whether it would shift treatment choices in aortoiliac occlusive disease and complex…

Read More